hyperinsulinism
Information
- Disease name
- hyperinsulinism
- Disease ID
- DOID:2018
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00004699 | Completed | N/A | Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism | August 1995 | January 1999 |
NCT00004700 | Completed | Phase 2 | Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism | August 1995 | January 1999 |
NCT00004825 | Completed | N/A | Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism | May 1998 | May 1998 |
NCT00005104 | Completed | N/A | Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome | January 2000 | |
NCT00005365 | Completed | Central Obesity and Disease Risk in Japanese Americans | February 1993 | January 1998 | |
NCT00005380 | Completed | Insulin, Androgen, and Risk in African-American Women | September 1993 | August 1998 | |
NCT00005530 | Completed | Diet, Insulin Resistance, and Cardiovascular Risk | May 1994 | April 2000 | |
NCT00005654 | Completed | N/A | Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome | January 2000 | |
NCT00005709 | Completed | Lipoprotein Metabolism in Hypertensive African-Americans | September 1993 | August 1998 | |
NCT00073775 | Completed | Epidemiology of Stress and the Metabolic Syndrome | September 2003 | August 2008 | |
NCT00074451 | Completed | Genomewide Search for Loci Underlying Metabolic Syndrome | September 2003 | August 2008 | |
NCT00151684 | Completed | Phase 2 | Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men | November 2004 | |
NCT00674440 | Completed | Phase 2 | Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism | December 2004 | January 2009 |
NCT00937079 | Completed | Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients | November 2007 | December 2011 | |
NCT02248272 | Completed | N/A | Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With Diabetes | October 2011 | September 2013 |
NCT03303196 | Completed | N/A | Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes | April 9, 2018 | September 30, 2019 |
NCT03358745 | Completed | N/A | Impact of Meal Order on Postprandial Cardiometabolic Risk Markers | June 1, 2016 | December 1, 2018 |
NCT03856606 | Completed | N/A | The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia | February 20, 2018 | July 8, 2018 |
NCT04327245 | Completed | N/A | To Compare the Effects of Non-nutritive Sweeteners Intake in Woman With Insulin Resistance | January 15, 2017 | October 25, 2019 |
NCT05329337 | Completed | N/A | Link Between the Peripheral Mononuclear Cells' Capacity to Induce Insulin Resistance and Hyperinsulinemia | June 27, 2022 | October 5, 2023 |
NCT05528874 | Completed | N/A | NUTRACORE, Glycaemic Index and Appetite | April 22, 2022 | September 1, 2023 |
NCT05764200 | Not yet recruiting | N/A | Acute Microbial Switch | July 1, 2023 | October 31, 2025 |
NCT05989347 | Not yet recruiting | Phase 1 | Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy | June 2024 | December 2025 |
NCT05950282 | Not yet recruiting | Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis | October 2023 | December 2026 | |
NCT05543083 | Recruiting | N/A | Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes | June 2, 2023 | April 30, 2027 |
NCT05662189 | Recruiting | N/A | Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus | March 15, 2022 | December 2024 |
NCT05088798 | Recruiting | Phase 2 | Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism | September 10, 2020 | January 1, 2030 |
NCT06363929 | Recruiting | Continuous Glucose Monitoring in Neonatal Hyperinsulinism | June 1, 2023 | December 31, 2025 | |
NCT05753657 | Recruiting | Early Phase 1 | A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer. | December 25, 2022 | December 31, 2027 |
NCT05774613 | Recruiting | N/A | Effect of Hibiscus Sabdariffa Beverage | June 12, 2021 | June 30, 2023 |
NCT04062890 | Unknown status | Phase 2 | Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance | December 15, 2019 | December 30, 2022 |
NCT04744896 | Unknown status | N/A | Effects Of Combined Cryolipolysis And High Intensity Interval Training On Insulin Resistance And Body Composition In Polycystic Ovarian Patients | March 1, 2021 | February 28, 2022 |
NCT02524639 | Withdrawn | Phase 1/Phase 2 | Sirolimus for the Treatment of Hyperinsulinism | August 12, 2015 | May 29, 2018 |
NCT03053284 | Withdrawn | Phase 2 | Pasireotide in Hyperinsulinemic Hypoglycemia | April 2017 | April 2018 |
- Disase is a (Disease Ontology)
- DOID:4194
- Cross Reference ID (Disease Ontology)
- ICD10CM:E16.1
- Cross Reference ID (Disease Ontology)
- MESH:D006946
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154694003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0020459
- Exact Synonym (Disease Ontology)
- hyperinsulinemia
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006946